MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer.
Luan R, He M, Li H, Bai Y, Wang A, Sun G, Zhou B, Wang M, Wang C, Wang S, Zeng K, Feng J, Lin L, Wei Y, Kato S, Zhang Q, Zhao Y.
Luan R, et al. Among authors: wei y.
EMBO Mol Med. 2024 Jan;16(1):10-39. doi: 10.1038/s44321-023-00003-z. Epub 2023 Dec 15.
EMBO Mol Med. 2024.
PMID: 38177530
Free PMC article.